AVEO Oncology
AVEO
#7408
Rank
C$0.74 B
Marketcap
C$21.51
Share price
0.00%
Change (1 day)
177.60%
Change (1 year)

Earnings for AVEO Oncology (AVEO)

Earnings in 2022 (TTM): -C$37.21 Million

According to AVEO Oncology 's latest financial reports the company's current earnings are C$94.31 Million. In 2021 the company made an earning of -C$76.49 Million a decrease over its 2020 earnings that were of -C$51.03 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AVEO Oncology from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -C$37.21 Million-51.36%
2021 -C$76.49 Million49.9%
2020 -C$51.03 Million-479.04%
2019 C$13.46 M-276.17%
2018 -C$7.65 Million-91.79%
2017 -C$93.1 Million142.38%
2016 -C$38.41 Million78.51%
2015 -C$21.52 Million-71.55%
2014 -C$75.62 Million-50.72%
2013 -C$0.16 Billion-4.88%
2012 -C$0.17 Billion-426.29%
2011 C$49.44 M-159.85%
2010 -C$82.63 Million35.33%
2009 -C$61.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
C$49.85 B-119,832.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$15.84 B-38,159.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$0.63 B-1,632.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$8.15 B-19,683.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$16.24 B-39,123.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-C$3.24 Million-92.22%๐Ÿ‡บ๐Ÿ‡ธ USA